Skip to main content
. 2021 Aug 3;12:709340. doi: 10.3389/fgene.2021.709340

TABLE 1.

Baseline characteristics of the choledochal cyst (CC) patients.

Fusiform (Ic) Cystic (Ia) p-value
Total 10 12
Female 5 50% 10 83.30% 0.095
Male 5 50% 2 16.70%
Age (months) 35 (30–42) 27 (15–34) 0.069
DB (μmol/L) 12.9 (2.4–63.7) 3.8 (1.3–12.1) 0.093
TB (μmol/L) 19.9 (9.4–69.7) 9.1 (6.1–19.1) 0.140
IB (μmol/L) 5.9 (4.8–9.1) 4.8 (3.6–5.5) 0.180
ALT (U/L) 65 (15–189) 27 (16–113) 0.628
AST (U/L) 54 (36–90) 59 (33–118) 0.872
γ-GGT (U/L) 374 (84–777) 82 (40–484) 0.314
ALP (U/L) 416 (318–553) 284 (235–366) 0.140
AMY (U/L) 68 (50–71) 66 (52–166) 0.674
PT (s) 11.3 (10.6–11.9) 11 (10.8–11.1) 0.497
APTT (s) 29.3 (28.7–29.9) 28.7 (26.5–30.7) 0.418

The parameters are presented as the median (IQR). IQR, interquartile range; DB, direct bilirubin; TB, total bilirubin; IB, indirect bilirubin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; γ-GGT, γ-glutamyl transpeptidase; ALP, alkaline phosphatase; AMY, amylase; PT, prothrombin time; APTT, activated partial thromboplastin time.